We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
The OPTIC Study: A Multicenter, Randomized, Phase 2 Trial to Evaluate Three Starting Doses of Ponatinib With Response-Based Dose Reduction in Patients with Chronic Phase Chronic Myeloid Leukemia Resistant to Prior Tyrosine Kinase Therapy.
- Authors
Gutierrez, Valentin García; Deininger, Michael W.; Baer, Maria R.; Kota, Vamsi K.; Akard, Luke; Chuah, Charles; Guerci-Bresler, Agnes; Hernández-Boluda, Juan Carlos; Neumann, Frank; Xu, Jing; Cortes, Jorge E.
- Publication
Clinical Lymphoma, Myeloma & Leukemia, 2018, Vol 18, pS228
- ISSN
2152-2650
- Publication type
Article
- DOI
10.1016/j.clml.2018.07.104